✦ LIBER ✦

Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): A risk adapted protocol of the Hellenic Cooperative Oncology Group

✍ Scribed by Aristotelis Bamias; Gerassimos Aravantinos; Ioannis Kastriotis; Gerassimos Alivizatos; Ioannis Anastasiou; Christos Christodoulou; Reveka Gyftaki; Haralambos P. Kalofonos; Meletios A. Dimopoulos

Book ID: 116956496
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 137 KB
Volume: 29
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2009.01.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two Cycles of Etoposide/Cisplatin Cured

Two Cycles of Etoposide/Cisplatin Cured All Patients with Stage I Testicular Seminoma: Risk-Adapted Protocol of the Hellenic Cooperative Oncology Group

✍ Aristotelis Bamias; Gerassimos Aravantinos; Charalambos Deliveliotis; Anastasios 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Randomized Phase III trial comparing ret

Randomized Phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical Stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German testicular cancer study group: Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group, Department of Urology, Klinikum Kassel GmbH, Kassel, Germany

✍ Donald L. Trump 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB